We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Kumar - Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide-Based Initial Therapy
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota, USA
12.06.11

Be the first to comment

 related articles